| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000021717 |
| Receipt No. | R000024850 |
| Official scientific title of the study | Prospective intervention study for antimicrobial effect of Agaricus bisporus agglutinin as functional food. |
| Date of disclosure of the study information | 2016/03/31 |
| Last modified on | 2016/03/31 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Prospective intervention study for antimicrobial effect of Agaricus bisporus agglutinin as functional food. | |
| Title of the study (Brief title) | Prospective intervention study for antimicrobial effect of Agaricus bisporus agglutinin as functional food. | |
| Region |
|
|
| Condition | ||
| Condition | Periodontitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | to investigate for antimicrobial effect of Agaricus bisporus agglutinin as functional food with prospective intervention study . |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | bacterial count on tooth surface |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | food with ABA | |
| Interventions/Control_2 | food without ABA | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 20 years of age or older of the university faculties, graduate students or research students.
A person the procedure of the informed consent has been completed, never forced. |
|||
| Key exclusion criteria | the exclusion criteria are allergic to mushroom, and pregnant or lactating. | |||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Shogo Tahashiba |
| Organization | Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Biopathological Science |
| Division name | Department of Pathophysiology - Periodontal Science |
| Address | 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8525, Japan |
| TEL | 086-235-6677 |
| shotakashi@gmail.com | |
| Public contact | |
| Name of contact person | Takashi Ito |
| Organization | Okayama University Hospital |
| Division name | Center for innovation clinical medicine |
| Address | 2-5-1 Shikata-cho, Kita-ku, Okayama |
| TEL | 086-235-6677 |
| Homepage URL | |
| gmd19073@s.okayama-u.ac.jp | |
| Sponsor | |
| Institute | Okayama University Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | MEXT(Japan) |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000024850 |